Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm

NCT00479050 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT00479050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00479050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm
Lead sponsor
Shandong University
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2001
Completion date
December 31, 2006
Enrollment
291 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma